Sleep Cycle (SLEEP) Stock Overview
Engages in providing sleep tracking applications in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
SLEEP Community Fair Values
Create NarrativeSee what 70 others think this stock is worth. Follow their fair value or set your own to get alerts.
Sleep Cycle AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 22.70 |
| 52 Week High | SEK 49.40 |
| 52 Week Low | SEK 21.60 |
| Beta | 0.17 |
| 1 Month Change | -14.34% |
| 3 Month Change | -17.75% |
| 1 Year Change | -45.17% |
| 3 Year Change | -24.33% |
| 5 Year Change | n/a |
| Change since IPO | -71.55% |
Recent News & Updates
Sleep Cycle AB (publ) (STO:SLEEP) Held Back By Insufficient Growth Even After Shares Climb 30%
Sep 09
Recent updates
Sleep Cycle AB (publ) (STO:SLEEP) Held Back By Insufficient Growth Even After Shares Climb 30%
Sep 09Weekly Picks: 💸 A dividend-rich sleep-tech play few investors are watching, and 2 other picks.
Aug 27Earnings Update: Sleep Cycle AB (publ) (STO:SLEEP) Just Reported And Analysts Are Trimming Their Forecasts
Apr 30The Market Doesn't Like What It Sees From Sleep Cycle AB (publ)'s (STO:SLEEP) Earnings Yet As Shares Tumble 34%
Apr 29Sleep Cycle's (STO:SLEEP) Dividend Will Be Increased To SEK3.00
Apr 08
Medical-Grade Sleep Apnea Certification Will Open New Healthcare Partnerships
Exploring medical-grade certification and new revenue streams could enhance profitability, opening healthcare markets through partnerships and innovation.Sleep Cycle's (STO:SLEEP) Upcoming Dividend Will Be Larger Than Last Year's
Mar 06Sleep Cycle (STO:SLEEP) Is Paying Out A Larger Dividend Than Last Year
Feb 10Sleep Cycle's Revenue Set to Rise 10% with Strong Business Model
Company will continue its trajectory of 10% top line growth p.a. with possibility of more aggressive growth should new business materialize (e.g. data monetization or making the app medical device forAre Investors Undervaluing Sleep Cycle AB (publ) (STO:SLEEP) By 46%?
Aug 16Sleep Cycle AB (publ) (STO:SLEEP) Just Reported, And Analysts Assigned A kr71.50 Price Target
Feb 17Shareholder Returns
| SLEEP | SE Software | SE Market | |
|---|---|---|---|
| 7D | -0.2% | -4.0% | -2.4% |
| 1Y | -45.2% | -29.9% | 1.9% |
Return vs Industry: SLEEP underperformed the Swedish Software industry which returned -29.9% over the past year.
Return vs Market: SLEEP underperformed the Swedish Market which returned 1.9% over the past year.
Price Volatility
| SLEEP volatility | |
|---|---|
| SLEEP Average Weekly Movement | 7.8% |
| Software Industry Average Movement | 8.1% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.1% |
Stable Share Price: SLEEP has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: SLEEP's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 35 | Erik Jivmark | www.sleepcycle.com |
Sleep Cycle AB (publ) engages in providing sleep tracking applications in Sweden. It develops sleep and health platforms. The company offers Sleep Cycle app, an application that provides sleep-related solutions.
Sleep Cycle AB (publ) Fundamentals Summary
| SLEEP fundamental statistics | |
|---|---|
| Market cap | SEK 460.30m |
| Earnings (TTM) | SEK 59.35m |
| Revenue (TTM) | SEK 256.76m |
Is SLEEP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SLEEP income statement (TTM) | |
|---|---|
| Revenue | SEK 256.76m |
| Cost of Revenue | SEK 106.76m |
| Gross Profit | SEK 150.01m |
| Other Expenses | SEK 90.66m |
| Earnings | SEK 59.35m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.93 |
| Gross Margin | 58.42% |
| Net Profit Margin | 23.11% |
| Debt/Equity Ratio | 0% |
How did SLEEP perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/22 02:36 |
| End of Day Share Price | 2025/11/21 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sleep Cycle AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Oscar Erixon | Carnegie Investment Bank AB |
| Rikard Engberg | DNB Carnegie Commissioned Research |
| Jessica Grunewald | Redeye |